Fennec Pharmaceuticals, Inc.
UnclaimedPharmaceutical Preparation ManufacturingDurham, NC
Founded
2003
Primary NAICS
325412
CAGE code
47VF2
Federal awards
$10.9K
Overview
Fennec Pharmaceuticals introduces Pedmark, a new compound developed to reduce the incidence of hearing loss in children undergoing chemotherapy. Learn more.
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- Pharmaceutical Preparation Manufacturing325412
Capabilities
Drugs and Biologicals
Federal awards
| Year | Agency | Obligated | Actions |
|---|---|---|---|
| 2026 | Department of Veterans Affairs | $0 | 2 |
| 2025 | Department of Veterans Affairs | $0 | 3 |
| 2024 | Department of Veterans Affairs | $10,891 | 3 |
| 2023 | Department of Veterans Affairs | $0 | 8 |